Can Inclisiran lower lipids to dangerous levels, and if so, when should it be discontinued?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18679222
Cited by: 0

Abstract

Currently, there is no clear evidence that inclisiran lowers LDL-C to dangerous levels nor established criteria for its discontinuation based on lipid levels alone.

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Antiplatelet Therapy and Cardiovascular Diseases Lipid metabolism and disorders

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
18 February 2026
Language
EN